Atrial Fibrillation Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You have been diagnosed with atrial fibrillation (an irregular heartbeat) that comes and goes, or that is ongoing
- You are already scheduled to have a catheter ablation procedure (a treatment for irregular heartbeat) that is approved by European heart guidelines
- You are between 18 and 85 years old
- You are able to understand and sign a consent form to take part in the study
Who may not be able to join:
- You are younger than 18 or older than 85 years of age
- A scan before the procedure found a blood clot in a part of your heart called the left atrial appendage
- Your heart failure has been rated as the most severe level (called NYHA Class IV), meaning you have serious symptoms even at rest (confirm with trial site)
- Your heart is pumping less than 30% of the blood it should with each beat (confirm with trial site)
- You have had a heart attack, severe chest pain (unstable angina), or open-heart bypass surgery within the last 6 months
- You have a serious other health condition — such as cancer, kidney failure requiring dialysis, severe lung disease, or liver cirrhosis — and are not expected to live more than 12 months
- You have a medical reason why you cannot have the catheter ablation procedure
- You are unable to understand or sign a consent form to take part in the study
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Stefano Carugo, MD, IRCCS Fondazione Cà Granda Ospedale Maggiore Policlinico
Phone: +390255033532
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Prevalence of subjects with AF undergoing ablation who have a reduction of inflammatory burden following treatment.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.